Decreased CSF somatostatin (Bissette et al., 1986; Tamminga et al., 1987) and decreased somatostatin immune-reactivity across cortical and subcortical regions is reported in subjects with Alzheimer’s disease, including temporal cortex, frontal cortex, and hippocampus (Davies et al., 1980; Rossor et al., 1980; Davies and Terry, 1981; Candy et al., 1985; Dournaud et al., 1994). The gene discussed is SST; the disease is Alzheimer disease.